Last reviewed · How we verify

NCT06609122: AAI

Impact of AAI Dogs on Performance and Behavior of Children with Autism

Recruiting now NA Last updated 25 September 2024
What this trial tests

NA trial testing Animal Assisted Intervention in Autism Spectrum Disorder (ASD) in 66 participants. Currently enrolling.

Timeline
1 April 2019
Primary endpoint
30 June 2025
31 December 2025

Quick facts

Lead sponsorThe University of Hong Kong
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment66
Start date1 April 2019
Primary completion30 June 2025
Estimated completion31 December 2025
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

Adults 6 to 18, any sex, with Autism Spectrum Disorder (ASD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental disorder usually diagnosed in early childhood. Children with ASD exhibit social communication and interaction problems, which may cause deficits in social-emotional reciprocity, problems with developing, maintaining, and understanding relationships, and abnormal nonverbal communicative behaviors such as impaired eye contact and body language. Some children with ASD have severe behavioral problems, such as stereotyped or repetitive motor movements, and extreme distress at small changes. ASD is a complex and individualized disorder, which creates challenges in treatment. Animal-assisted education (AAE) programmes have been introduced for children with special needs in other countries such as the United States and Australia. PAALS (Palmetto Animal Assisted Life Services) in the United States have introduced the Pet a PAALS Dog programme, which assists stressed students at USC (University of South Carolina). Assistance Dogs Australia has provided an Educational Support Dog Echo to Kalinda Support School, for children with a wide range of disabilities. Existing literature indicate the benefit of animal-assisted therapy on physical, behavioral, and cognitive disabilities, especially in social and communication disorders. Formally trained human-dog teams in animal-assisted interventions (AAI) can play a unique role in social and communicative development that schools, and caregivers may not be able to provide. Interacting with animal-assisted intervention dogs can increase children with ASD\'s social interaction, communication, and effective connection. Dogs can also provide emotional support in stressful situations such as calming the child down when they have a tantrum. Moreover, animal-assisted therapy has shown to decrease stress levels, anxiety, and restrictive and repetitive behavior patterns. Dogs as pets can also bring significant improvements to caregivers of children with ASD and improve conflict management. Based on a successful pilot trial in 2019 with 8 children showed that AAI program has a positive effect on the performance of children with ASD, The investigator proposed an observational study that tracks the effectiveness of an animal-assisted intervention programme in a local school for children with ASD and developmental disabilities.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Dog-assisted therapy on Hong Kong children with autism spectrum disorder: an exploratory randomized controlled trial.
    Wong WHS, Chen C, Tso A, So HK, et al · · 2026 · PMID 41511681 · DOI 10.1007/s00431-025-06720-6

Verify or expand the search:

Other trials of Animal Assisted Intervention

Trials testing the same drug.

Other recruiting trials for Autism Spectrum Disorder (ASD)

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06609122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing